Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Softer Late Afternoon

Sector Update: Healthcare Stocks Softer Late Afternoon

MT newswireMT newswire2026/10/08 19:53

03:53 PM EDT, 10/08/2026 (MT Newswires) -- Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%. The iShares Biotechnology ETF (IBB) fell 1.4%. In corporate news, Viatris (VTRS) said it has agreed to buy Pacira BioSciences (PCRX) in an all-cash deal worth about $1.65 billion to strengthen its non-opioid pain management portfolio. Viatris shares were down 0.7%, and Pacira surged 44%. Argenx (ARGX) said it will discontinue a phase 3 study of efgartigimod subcutaneous in adults with Sjogren's disease following a recommendation from an independent data monitoring committee. Shares fell past 11%. ADC Therapeutics (ADCT) shares jumped past 11% after the firm reported a financial restructuring to bolster its balance sheet, extend cash runway into 2029, reduce leverage, and ramp strategic optionality to drive shareholder value. Editas Medicine (EDIT) shares rose 2% after the company received approval in Australia to initiate a phase 1/2 trial of EDIT-401 in people with heterozygous familial hypercholesterolemia.

03:53 PM EDT, 10/08/2026 (MT Newswires) -- Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%. The iShares Biotechnology ETF (IBB) fell 1.4%. In corporate news, Viatris (VTRS) said it has agreed to buy Pacira BioSciences (PCRX) in an all-cash deal worth about $1.65 billion to strengthen its non-opioid pain management portfolio. Viatris shares were down 0.7%, and Pacira surged 44%. Argenx (ARGX) said it will discontinue a phase 3 study of efgartigimod subcutaneous in adults with Sjogren's disease following a recommendation from an independent data monitoring committee. Shares fell past 11%. ADC Therapeutics (ADCT) shares jumped past 11% after the firm reported a financial restructuring to bolster its balance sheet, extend cash runway into 2029, reduce leverage, and ramp strategic optionality to drive shareholder value. Editas Medicine (EDIT) shares rose 2% after the company received approval in Australia to initiate a phase 1/2 trial of EDIT-401 in people with heterozygous familial hypercholesterolemia.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq

Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

智通财经•2026/11/09 06:12
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq